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Micronutrient Deficiency Independently Predicts Time to Event in
Patients With Heart Failure
Terry A. Lennie, PhD, RN, FAAN; Christina Andreae, PhD, RN; Mary Kay Rayens, PhD; Eun Kyeung Song, PhD, RN; Sandra B. Dunbar, DNS,
RN, FAAN; Susan J. Pressler, PhD, RN, FAAN; Seongkum Heo, PhD, RN; JinShil Kim, PhD, RN; Debra K. Moser, PhD, RN, FAAN
Background-—Dietary micronutrient deficiencies have been shown to predict event-free survival in other countries but have not
been examined in patients with heart failure living in the United States. The purpose of this study was to determine whether
number of dietary micronutrient deficiencies in patients with heart failure was associated with shorter event-free survival, defined
as a combined end point of all-cause hospitalization and death.
Methods and Results-—Four-day food diaries were collected from 246 patients with heart failure (age: 61.512 years; 67% male;
73% white; 45% New York Heart Association [NYHA] class III/IV) and analyzed using Nutrition Data Systems for Research.
Micronutrient deficiencies were determined according to methods recommended by the Institute of Medicine. Patients were followed
for 1 year to collect data on all-cause hospitalization or death. Patients were divided according to number of dietary micronutrient
deficiencies at a cut point of ≥7 for the high deficiency category versus <7 for the no tomoderate deficiency category. In the full sample,
29.8% of patients experienced hospitalization or death during the year, including 44.3% in the high-deficiency group and 25.1% in the
no/moderate group. The difference in survival distribution was significant (log rank, P=0.0065). In a Cox regression, micronutrient
deficiency category predicted time to event with depression, NYHA classification, comorbidity burden, body mass index, calorie and
sodium intake, and prescribed angiotensin-converting enzyme inhibitors, diuretics, or b-blockers included as covariates.
Conclusions-—This study provides additional convincing evidence that diet quality of patients with heart failure plays an important
role in heart failure outcomes. ( J Am Heart Assoc. 2018;7:e007251. DOI: 10.1161/JAHA.117.007251.)
Key Words: diet • heart failure • nutrition • risk factor • survival analysis
S odium has been the primary nutrient of interest in heartfailure management for >60 years because of its relation-
ship with fluid retention, symptoms, and hospitalizations.1,2
Nevertheless, nutrition in heart failure is recognized to extend
beyond sodium3 and may be equally important for manage-
ment as drugs and devices.4 Accumulating evidence suggests
that micronutrient deficiencies are common in patients with
heart failure,5–10 but less evidence shows the relationship of
micronutrient deficiencies to heart failure outcomes.11–13 A
recent study by Song and Kang14 demonstrated that micronu-
trient deficiencies independently predicted cardiac event-free
survival in patients with heart failure living in South Korea.
Patients’ risk of hospitalization or death increased by 14% for
each additional micronutrient that was deficient in the diet. The
purpose of this study was to determine whether micronutrient
deficiencies in patients with heart failure living in the United
States were associated with similar risks.
Specific aims were (1) to determine dietary nutritional
status based on 4-day food diaries; (2) to examine associa-
tions between nutritional deficiencies and demographic and
clinical variables; and (3) to assess whether the degree of
nutritional deficiency was predictive of time to event (all-
cause hospitalization or death), controlling for demographic
and clinical covariates.
Methods
The data, analytic methods, and study materials will be made
available to other researchers for purposes of reproducing the
results or replicating the procedure by the corresponding
author upon reasonable request.
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Study Design and Population
This multicenter longitudinal study included 274 patients
with heart failure recruited from 3 heart failure clinics
affiliated with academic medical centers located in Georgia,
Indiana, and Kentucky. Inclusion criteria were (1) confirmed
diagnosis of heart failure with either reduced or preserved
ejection fraction, (2) New York Heart Association (NYHA)
classification I–IV, (3) stability on medication regimen for
3 months before enrollment, (4) no history of hospitalization
in the 3 months before enrollment, (5) ability to speak and
write English, and (6) no obvious cognitive impairment.
Exclusion criteria were (1) status 1 on a cardiac transplant
list or the presence of a left ventricular assist device;
(2) end-stage kidney (on dialysis), liver, or pulmonary
disease; (3) active cancer treatment or cancer likely to cause
death within 12 months; and (4) any health condition that
required dietary restrictions other than those for heart
failure or diabetes mellitus. Eight participants withdrew and
14 participants whose average 4-day kcal intake from food
diary was <40% of estimated energy requirements were
excluded from the analysis.10 Another 6 participants were
omitted from this analysis because they were missing either
days of follow-up or a depressive symptoms score (ie, Beck
Depression Inventory II [BDI-II]). The final sample comprised
246 patients.
Measures
Demographic factors
Data on age, sex, and race were collected by patient
interview. Body mass index (BMI) defined as weight in
kilograms divided by height in square meters (kg/m2) was
calculated for inclusion in the analysis.
Heart failure classification
The NYHA functional classification was used to summarize
heart failure severity. This variable was dichotomized into III/
IV versus I/II before analysis. NYHA functional class was
determined by careful patient interview using a standardized
form. Reproducibility both among different raters (interrater
reliability) and for the same rater (intrarater reliability) at each
site was ensured by training raters and testing them with
sample patients until interrater agreement was 100%.
Prescription drugs
Prescribed medication regimens (ie drugs, doses, frequencies)
were obtained from patient interview and medical record
review to confirm patient report. Four indicator variables were
created, one each for angiotensin-converting enzyme inhibitor
prescription (yes/no), angiotensin receptor blocker prescrip-
tion (yes/no), diuretic prescription (yes/no), and b-blocker
prescription (yes/no).
Comorbidities
Comorbidity burden was determined by the Charlson Comor-
bidity Index interview format.15 Total scores could range from
1 to 34. Reliability and validity have been demonstrated.15,16
The total comorbidity score was used in the analysis.
Depressive symptoms
The BDI-II17–19 was used to assess level of depressive
symptoms in the sample. This 21-item instrument measures
the degree of depressive symptoms, such as pessimism,
agitation, and loss of energy, with most items scored on a 0 to
3 scale; 2 of the items are scored on a 0 to 6 scale and then
rescaled to range from 0 to 3 before inclusion in the total.
Higher scores on each item indicate greater depressive mood,
and the total score is the sum of all 21 items. Scores >13 are
indicative of clinically significant depressive symptoms.20
Cronbach’s a for this sample is 0.91.
Laboratory values
Blood was drawn for NT-proBNP (N-terminal probrain natri-
uretic peptide), serum sodium, and uric acid during the
baseline visit to the clinical research center at each site.
Serum sodium and uric acid were measured at each
participating site’s hospital laboratory using standard labora-
tory methods. Blood for NT-proBNP was shipped to the
Clinical Perspective
What Is New?
• High dietary micronutrient deficiency was a strong inde-
pendent predictor of 1-year hospitalization or death in a
sample of patients from the United States.
• Most common dietary nutrient deficiencies were in calcium,
folate, magnesium, zinc, and vitamins C, D, E, and K.
• Patients with comorbid depressive symptoms may be par-
ticularly vulnerable to dietary micronutrient deficiencies.
• Patients with high body mass indexes were equally likely to
have diets high in micronutrient deficiencies.
What Are the Clinical Implications?
• Nutritional deficiency is an important risk factor for
hospitalization and death in patients with heart failure.
• Patients should be assessed for potential dietary deficien-
cies regardless of body mass index.
• The wide range of micronutrient deficiencies suggests
that a focus on promoting a varied diet is necessary
to prevent patients having multiple micronutrient
deficiencies.
• Patients at high risk for dietary micronutrient deficiencies
may benefit from consultation with a dietitian.
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primary site. Plasma levels of NT-proBNP were measured by
the core laboratory at the primary site clinical research center
using a commercially available ELISA kit. Assays were run in
duplicate, and when the inter- and intra-assay coefficients of
variation (reflecting accuracy and reproducibility) were unac-
ceptable (coefficient of variation >10%), the assay was
redone.
Seattle Heart Failure Model
The Seattle Heart Failure Model score was included in the
analysis to control for covariates associated with event-free
survival. The model score was calculated using the Windows
version of the Seattle Heart Failure Model calculator for the
web (https://depts.washington.edu/shfm/?width=1366&he
ight=768) and included age, sex, ischemic origin of heart
failure, systolic blood pressure, ejection fraction, medication
(angiotensin-converting enzyme inhibitor, angiotensin recep-
tor blocker, aldosterone blocker, b-blocker, statins, diuretic
type and daily dose, and allopurinol), laboratory values (serum
sodium, total cholesterol, hemoglobin, percent lymphocytes,
and uric acid), body weight, and NYHA functional class. The
presence of an implantable device (pacemaker, implantable
cardioverter-defibrillator, or cardiac resynchronization ther-
apy) was also included.21 Default values for systolic blood
pressure (120 mm Hg) and lymphocyte percentage (24%)
were used because they were not collected at baseline. Data
on presence of left bundle-branch block and QRS >150 ms
were also missing and subsequently not included in score
calculation. Seattle Heart Failure Model scores are strong
predictors of hosptializtion22 and both shorter (1-year) and
longer (2- and 3-year) survival.23
Number of nutritional deficiencies
Nutritional intake averaged over the 4 days was determined
using Nutritional Data Systems-R software (Nutrition Coordi-
nating Center, University of Minnesota). Dietary adequacy of
17 micronutrients (11 vitamins and 6 minerals) was defined
according to recommendations outlined by the Food and
Nutrition Board of the Institute of Medicine.24 For 7 micronu-
trients (magnesium, folate, vitamin B6, niacin, thiamin,
riboflavin, and phosphorus), sufficient population-based data
were available for the Food and Nutrition Board to establish
parameters to calculate a probability ratio that a patient’s diet
was habitually high or low in a micronutrient based on a 4-day
food diary. A ratio <1 indicated a high probability that the
patient’s diet was habitually low in that micronutrient. For 8
micronutrients (calcium, iron, selenium, zinc, and vitamins B12,
C, D, and E), diet adequacy was based on estimated average
requirement because probability formulas have not been
established. Micronutrient deficiency was defined as intake
below the estimated average requirement for each micronu-
trient. For 2 vitamins (vitamin K and pantothenic acid), only
the recommended daily allowance has been established. Diet
deficiency for these micronutrients was defined as intake
<50% of the recommended daily allowance for each micronu-
trient. The number of micronutrient deficiencies was summed.
Because this variable was skewed to the right, we created a
binary variable using the cut point of ≥7 for the high deficiency
category. This value was chosen because 25% of the sample
had a score at or above this level; this type of dichotomy has
been used previously with skewed clinical predictors of heart
failure outcomes.25 Participants with fewer micronutrient
deficiencies were classified as no to moderate deficiency.
Event-free survival
Patients kept a diary of all hospitalizations and were called
monthly by a trained research assistant to obtain hospitaliza-
tion data for 1 year following baseline data collection using a
well-validated life history method.26,27 All hospitalizations
were verified by medical record review. When patient recall
varied from the medical records, the medical record was
considered the gold standard. With patient or family assis-
tance, hospital discharge and other medical records were
obtained from identified sources of care outside of the study-
site healthcare systems. We have >20 years of experience
collecting these data and have successfully obtained hospi-
talization data on all rural patients in our current and previous
studies.28–41 All-cause mortality data (date and cause of
death) were collected for 1 year from baseline by a combi-
nation of medical record review, electronic clinical record
review, interviews with patients’ healthcare providers and
family, and public death record review.30,31,40–43
Procedure
The study was approved by the institutional review board at
each site before start of study. All participants gave signed
informed consent before data collection, which occurred
between June 2006 and March 2009. Patients were referred
by nurse practitioners to a research assistant who verified
eligibility. For those who agreed to participate, appointments
were made by a trained research nurse to visit them in their
homes to complete all questionnaires and to provide the
equipment (food diary, digital food scale, food portion models,
and food portion pictures) and detailed instructions for filling
out the 4-day food diary. Patients did a return demonstration
so investigators could verify understanding and provide an
opportunity to clarify procedures. Patients recorded all foods,
liquids, and dietary supplements consumed for 1 weekend day
and 3 weekdays. The research nurse called the morning of the
first recording day to again verify understanding and answer
any questions about recording the food diary. Patients who
consumed packaged foods were instructed to bring the empty
packages with them with the food diary. The morning
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following completion of food diary, patients visited the clinical
research center at each site for measurement of height and
weight and for review of the food diary. A dietician at each site
carefully reviewed the food diaries with the patients, and
spouses if appropriate, to clarify information regarding
ingredients, verify portion sizes, and obtain any missing data
(eg, preparation methods). The interviews averaged 30 to
45 minutes. The completed food diaries from all sites were
entered into the Nutritional Data Systems-Research software
package (Nutrition Coordinating Center, Minneapolis, MN) at
the primary site by a trained research assistant. Data entry
was verified by the primary investigator (T.A.L.). Patients, or
family members if patients were not available, were followed
for 1 year by monthly phone calls to collect data on
hospitalizations and mortality. Data were verified by reviewing
hospital records.
Data Analysis
Descriptive statistics, including means and standard deviations
or frequency distributions, were used to summarize the study
variables. Both arithmetic and geometric means and their 95%
confidence intervals (CIs) were used to summarize micronutri-
ent intake. Comparisons between the no- to moderate-
deficiency group and the high-deficiency group were accom-
plished using the 2-sample t test or v2 test of association.
Although other clinical variables had distributions that were
approximately normal, NT-proBNP was log-transformed before
group comparison because of a right-skewed distribution.
Predictors of event-free survival were assessed using Cox
regression. Several Cox regression models were run, and the
proportional hazards assumption was tested by introducing
time-dependent covariates in the fitted main effects models.
The first model, based on the full sample (N=246), included
nutrient deficiencies as the predictor of event-free survival, with
race, total comorbidities, depressive symptoms, sodium
intake/1000 kcal, and Seattle Heart Failure Model score as
covariates. The second model included all the same variables
plus log-transformed NT-proBNP as an additional covariate. The
sample size for this model was smaller (n=222) because NT-
proBNP was not available for all patients. Third, because kcal
intake was lower in the high-deficiency group, we ran a
sensitivity analysis with kcal/kg added to the Cox model that
included the full sample. For each Cox regression, the
proportionality test evaluated whether the required condition
of proportional hazards was met, whereas variance inflation
factors were used to assess the presence of multicollinearity.
Finally, the bivariate association between deficiency group
status and time to event (all-cause hospitalization or death) was
evaluated with the log rank test and graphed using a Kaplan–
Meier plot. Data analysis was done using SAS v9.3 (SAS
Institute); an a level of 0.05 was used throughout.
Results
On average, the participants were aged 61 years (range: 24–
97 years; see Table 1). They were predominantly male and
white, with NYHA classification of I or II. Most participants
were prescribed angiotensin-converting enzyme inhibitors,
diuretics, and/or b-blockers; a fifth were prescribed an
angiotensin receptor blocker. The mean comorbidity score
was 3 (range: 1–8). The majority of participants were
overweight or obese (24% normal weight, 29% overweight,
24% obese class 1, and 23% obese class 2 or 3).44
The median number of micronutrient deficiencies in
patients’ diets was 4 (range: 0–14). Comparing those with
high micronutrient deficiency to those with no to moderate
deficiency, the high-deficiency group was younger, more likely
to be black or other minority, and other minority (Asian,
Hispanic, or Native American) had higher depressive symp-
toms scores. The percentage of participants in the high-
deficiency group was relatively evenly distributed across BMI:
22% were normal weight, 29% were overweight, 26% were
obese class 1, and 23% were obese class 2 or 3. Those in the
high-deficiency group had lower kcal and sodium intake than
the no- to moderate-deficiency group. The 2 groups also
differed on the ratio of sodium per 1000 kcal, with the
average for the high-deficiency group being 12% higher than
the no- to moderate-deficiency group. The 2 deficiency
groups did not differ by sex; NYHA classification group; left
ventricular ejection fraction <50%; serum sodium, uric acid, or
NT-proBNP; prescribed angiotensin-converting enzyme inhibi-
tors, angiotensin receptor blocker, diuretics, or b-blockers;
number of comorbidities; BMI; or Seattle Heart Failure Model
score.
The summary of deficiency status for each micronutrient is
given in Table 2. The table entries are ordered from greatest
percentage of participants with a micronutrient deficiency to
least, with recommended daily micronutrient requirements for
men and women aged 51 to 70 provided as reference values.
Both the arithmetic and geometric means are given for the
level of consumption of each micronutrient, along with the CIs
for each. The micronutrients most often deficient included
calcium, magnesium, and vitamins D and E, whereas phos-
phorus, niacin, thiamin, and riboflavin were less frequently
deficient.
The Cox regression model to assess predictors of time to
event was significant overall (likelihood ratio, v2=26.6,
P<0.001). With demographic and clinical variables included
as covariates, number of comorbidities, depressive symp-
toms, and high micronutrient deficiency status were signifi-
cant predictors of time to all-cause hospitalization or death,
whereas race, BMI, sodium intake per 1000 kcal, comorbidity
score, and Seattle Heart Failure Model score were not
significant (model 1; Table 3). For every 5-U increase in BDI-II
score, the hazard of having a hospitalization or death
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increased by 15%. Compared with those with no or moderate
micronutrient deficiency, those with high deficiency had
92% greater hazard of hospitalization for or death from any
cause.
The second model included the demographic and clinical
characteristics of the first with the addition of log-transformed
NT-proBNP (model 2; Table 3). The significant predictors in this
model included depressive symptoms, NT-proBNP, and defi-
ciency status, and the overall model was significant (likelihood
ratio, v2=39.5, P<0.001). This model was largely consistent
with the prior model except that number of comorbidities no
longer met the threshold for significance, and the sample size
was diminished by 24 (the number of participants for whom NT-
proBNP was not measured). In this model, a 5-point increase in
BDI-II was associated with a 22% increase in the hazard of
hospitalization or death. Those with high micronutrient defi-
ciency had double the hazard of all-cause events compared with
the reference group of no to moderate deficiency. The hazard
ratio for the log of NT-proBNP suggested that those with
increased values for this measure had greater hazard of
experiencing an event (ie, 2.8 times the hazard for each 1-U
increase in the log of NT-proBNP). For both models, the test of
proportionality was not significant (P>0.68 for both), and the
variance inflation factors were <1.2 for each independent
variable in the model, suggesting that multicollinearity did not
distort parameter estimates.
Table 1. Sociodemographic and Clinical Characteristics of the Study Sample by Micronutrient Deficiency Status, With Group
Comparisons Using 2-Sample t Tests or v2 Tests of Association
Full Sample (N=246)
Micronutrient Deficiency Status
P ValueNo to Moderate Deficiency (n=185) High Deficiency (n=61)
Age,* y 61.4 (12.0); 24–97 62.6 (12.1); 32–97 57.9 (11.1); 24–83 0.007
Sex 0.40
Male, n (%) 164 (67) 126 (68) 38 (62)
Race, n (%) 0.001
White 180 (73) 145 (78) 35 (57)
Black or other minority 66 (27) 40 (22) 26 (43)
NYHA classification, n (%) 0.22
I/II 133 (54) 104 (57) 29 (48)
III/IV 112 (46) 80 (43) 32 (52)
LVEF <50%, n (%) 212 (86) 160 (86) 52 (85) 0.81
Serum sodium, mmol/dL* 138.9 (2.4); 129–145 138.9 (2.4); 129–145 139.2 (2.5); 132–145 0.38
Uric acid, mg/dL* 6.9 (1.8); 2.3–16.0 6.9 (1.8); 2.3–16.0 6.9 (1.9); 3.4–12.3 0.83
NT-proBNP, fmol/mL, mean; 95% CI*‡ 610.7; 553.0–674.4§ 638.7; 567.2–719.2§ 529.4; 445.6–628.9§ 0.08
ACEI, yes, n (%) 164 (69) 124 (69) 40 (67) 0.71
ARB, yes, n (%) 50 (21) 35 (19) 15 (26) 0.28
Diuretic, yes, n (%) 184 (76) 138 (76) 46 (75) 0.95
Β-blocker, yes, n (%) 216 (89) 160 (87) 56 (92) 0.35
Number of comorbidities* 3.0 (1.8); 1–8 3.0 (1.7); 1–8 2.9 (2.0); 1–8 0.92
BMI* 30.4 (7.1); 16.8–61.3 30.1 (6.9); 16.8–61.3 31.2 (7.4); 18.1–51.3 0.31
Depressive symptoms (BDI-II)* 10.5 (8.3); 0–41 9.8 (8.3); 0–41 12.8 (8.2); 0–38 0.02
Calorie intake* 1852 (639); 716–4363 1970 (656); 716–4363 1493 (417); 775–2870 <0.001
Sodium intake* 3198 (1306); 888–9138 3309 (1353); 888–9138 2861 (1091); 890–6003 0.01
Sodium intake/1000 kcal* 1.8 (0.5); 0.4–3.8 1.7 (0.4); 0.4–3.4 1.9 (0.6); 0.6–3.8 0.005
Seattle Heart Failure Model score* 11.3 (4.6); 2.6–27.4 11.3 (4.7); 2.6–27.4 11.3 (4.3); 3.7–23.4 0.99
Data are shown as mean (SD); range, except as noted. ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BDI-II, Beck Depression Inventory II; BMI,
body mass index; CI, confidence interval; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal probrain natriuretic peptide; NYHA, New York Hospital Association.
*Group comparisons done with 2-sample t test; all other comparisons accomplished using v2 test of association.
‡Whereas all other study variables were missing for at most 7 participants, this one was missing for 24.
§As a correction for skewness, a log transformation was used before the group comparison of NT-proBNP; the values shown in the table for this variable are the geometric mean and
corresponding 95% CI.
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In the sensitivity analysis with kcal/kg added to the full-
sample model, deficiency status remained a significant
predictor of event-free survival (likelihood ratio, v2=4.25,
P=0.039). The CI for the hazard ratio for this predictor was
relatively wide, suggesting increased variability related to the
inclusion of kcal/kg, likely caused by the strong association
between kcal and deficiency status. The estimated hazard
ratio for deficiency status in this model was 4.87, and the
corresponding 95% CI was 1.08 to 21.89. This model also had
a nonsignificant proportionality of hazards test (P=0.83), and
the variance inflation factors were all <1.7.
In the full sample, 30.1% of patients experienced hospital-
ization or death during the year. There were 2 deaths (3%) and
25 hospitalizations (41%) in the high-deficiency group and 3
(2%) deaths and 44 hospitalizations (24%) in the no/moderate-
deficiency group. The Kaplan–Meier plot shown in the Figure
provides a graphical representation of the survival distribution
over 1-year follow-up for the 2 micronutrient deficiency status
groups. At the end of the yearlong follow-up period, both
groups had >50% surviving event free, so the median event-
free survival time was not estimable; however, the upper
quartile (ie, with 75% surviving event-free) was 193 days (95%
CI, 103–303) for the high-deficiency group compared with
333 days for the no/moderate deficiency group (the lower
95% confidence limit was 225, and the upper confidence limit
was not estimable given the limited number of events in this
group). Mean survival was 266.5 days (SE: 14.1) and
312.9 days (SE: 7.7) for the high- and no/moderate-
deficiency groups, respectively. In Figure, the survival distri-
bution for the group with high deficiency is below than the
group with a more complete diet. Consistent with the
observed difference in distributions, the log rank test for the
group comparison was significant (v2=7.6; P=0.0065).
Discussion
Our results using a sample of patients with heart failure
from the United States were similar to those of Song and
Kang14 using a sample of patients from South Korea. The
Kaplan–Meier plot and log rank test demonstrate the
shortest event-free survival was among patients in the high
micronutrient deficiency group. Their event hazard was an
alarming 93% higher than patients with fewer micronutrient
deficiencies.
Table 2. Summary of the Micronutrients, Including the Reference of Lowest Micronutrient Intake/Day for Men and Women Aged
51–70 Years, Percentage of the Sample With Deficiency, and Arithmetic and Geometric Means and Their Corresponding 95% CIs
(N=246)
Variable
Reference
% Deficient
Untransformed Data Log-Transformed Data
Micronutrients/Day, Men; Women Mean (Arithmetic) 95% CI Mean (Geometric) 95% CI
Calcium, mg* 1.0; 1.2 67.1 862.1 801.5–922.6 747.9 699.1–800.2
Magnesium, mg† 420; 320 62.2 301.9 284.6–319.3 275.3 260.9–290.6
Vitamin D, qg‡ 15; 15 60.6 9.2 7.9–10.6 5.8 5.1–6.6
Vitamin E, mg* 15; 15 59.4 82.0 44.8–119.2 13.0 10.8–15.6
Zinc, mg* 11; 8 45.5 15.5 14.0–17.0 12.8 11.8–13.8
Vitamin C, mg* 90; 75 39.4 185.8 123.0–248.5 83.7 72.5–96.8
Vitamin K, qg‡ 120; 90 29.7 109.4 97.1–121.8 81.5 74.0–89.7
Folate, qg† 400; 400 27.2 548.7 502.6–594.9 463.7 431.5–498.3
Vitamin B12, qg* 2.4; 2.4 9.4 50.6 4.5–96.7 7.5 6.4–8.7
Pantothenic acid, mg‡ 5; 5 4.1 9.7 7.7–11.7 6.7 6.1–7.4
Vitamin B6, mg
† 1.7; 1.5 3.3 3.4 2.5–4.3 2.3 2.1–2.5
Selenium, qg‡ 55; 55 2.0 117.3 110.2–124.4 107.7 102.4–113.4
Iron, mg* 8; 8 2.0 20.9 16.9–24.8 16.4 15.2–17.6
Phosphorus, mg† 700; 700 1.6 1200.0 1145.4–1254.6 1129.1 1080.8–1179.6
Niacin, mg3 16; 14 1.6 54.7 33.6–75.9 29.3 26.6–32.1
Thiamin, mg† 1.2; 1.1 0.4 4.8 2.3–7.2 2.1 1.9–2.3
Riboflavin, mg† 1.3; 1.1 0 3.6 2.6–4.5 2.5 2.3–2.7
CI indicates confidence interval.
*Deficiency status based on estimated average requirement.
†Deficiency status based on probability formula.
‡Deficiency status based on <50% recommended daily allowance.
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A large number of patients in our study had diets deficient
in calcium, folate, magnesium, zinc, and vitamins C, D, E, and
K. This finding is similar to a study from Canada10 and 2 from
South Korea14,42 in which the same methods were used to
measure nutritional intake and to define micronutrient
deficiencies. Dietary deficiencies in calcium and magnesium
measured by a variety of other methods have also been
reported in studies from the United States,6,45 Brazil,9,46
Ireand,47 and Italy.7 Other commonly reported dietary
deficiencies include vitamin D,45–47 vitamin E,6,7,45 and
zinc.7,9,45 This high level of micronutrient deficiency is not
confined to adults with heart failure. Diets of age- and sex-
matched adults without and with heart failure have been
reported to be comparably poor in several studies.5,7,10
Nevertheless, because patients with heart failure have
enhanced excretion of water-soluble vitamins from diuretic
therapy and evidence of increased metabolic demand,48 these
deficiencies may have greater consequences for patients with
heart failure than without.
A cause for the high number of micronutrient deficiencies
in older adults may be diet monotony. Eating a varied diet has
been shown to be positively correlated with dietary micronu-
trient adequacy49—that is, the greater the diversity of foods
in the diet, the less likely there are to be dietary deficiencies.
This is particularly true for calcium,49 the micronutrient most
commonly deficient in the diets of patients with heart failure.
Anecdotally, we observed that a large number of our patients
consumed the same foods for multiple meals across all
4 days of the food diary. Consistent with this observation are
data suggesting that older adults are more vulnerable to
consuming a monotonous diet because of a decreased drive
to consume varied foods. Pelchat and Shaefer50 compared
food cravings in a group of young adults (mean age: 25 years)
with a group of older adults (mean age: 73 years) before and
while on a 5-day, monotonous, nutritionally complete liquid
diet. The number of cravings was similar in the groups at
baseline. During the diet monotony period, young adults
reported a significant increase in the number of cravings,
whereas older adults reported no increase in cravings. The
older adults also indicated a greater liking of the monotonous
diet than the younger adults. Supporting our anecdotal
observation, these results indicate that older adults with
heart failure may be prone to eating diets with limited
variability, placing them at risk for dietary micronutrient
deficiencies.
In addition to diet monotony, other factors related to heart
failure and aging may also affect food intake. We conducted a
study comparing heart failure patients’ perceptions of factors
influencing food intake with a similar group of healthy older
adults.51 Factors with greater impact for patients with heart
failure were dietary restrictions, lack of hunger, feeling full
after eating only a small amount of food, shortness of breath,
Table 3. Cox Proportional Hazards Models for Time to All-Cause Hospitalization or Death
Variable Parameter Estimate SE HR 95% CI v2 (P Value)
Model 1 (N=246)
White 0.1721 0.2739 1.19 0.69 to 2.03 0.4 (0.39)
Comorbidity score 0.1142 0.0649 1.21 0.99 to 1.27 3.1 (0.08)
BMI 0.0265 0.0175 1.03 0.99 to 1.06 2.3 (0.13)
BDI-II 0.0324* 0.0131* 1.03* 1.01 to 1.06* 6.1 (0.01)
Sodium intake/1000 kcal 0.1878 0.2567 0.83 0.50 to 1.37 0.5 (0.46)
Seattle Heart Failure Model score 4.326 2.303 0.01 0.00 to 1.21 3.5 (0.06)
Have high deficiency 0.6519* 0.2621* 1.92* 1.15 to 3.21* 6.2 (0.012)
Model 2 (n=222)
White 0.2322 3182 1.27 0.68 to 2.35 0.5 (0.46)
Comorbidity score 0.0883 0.0684 1.09 0.96 to 1.25 1.7 (0.20)
BMI 0.0312 0.0201 1.03 0.99 to 1.07 2.6 (0.11)
BDI-II 0.0427* 0.0143* 1.04* 1.02 to 1.07* 8.9 (0.003)
Sodium intake/1000 kcal 0.1178 0.2548 1.12 0.68 to 1.85 0.2 (0.64)
Seattle Heart Failure Model score 2.206 3.594 9.08 0.01 to 10 416 0.4 (0.54)
NT-proBNP 1.014* 0.2228* 2.76* 1.78 to 4.27* 21 (<0.001)
Have high deficiency 0.7021* 0.2892* 2.02* 1.14 to 3.58* 5.9 (0.01)
BDI-II indicates Beck Depression Inventory-II; BMI, body mass index; CI, confidence interval; HR, hazard ratio; NT-proBNP, N-terminal probrain natriuretic peptide.
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and limited energy. Factors common in both groups, and
presumably more related to aging than heart failure, were
decreased senses of taste and smell.
Patients attempting to follow a very low sodium diet
(<2000 mg) have been reported to develop dietary micronu-
trient deficiencies, suggesting that sodium-restricted diets
may contribute to dietary deficiencies.52 Although the group
with higher micronutrient deficiency in our study also had
significantly lower daily sodium intake, 2 observations suggest
that sodium restriction may not have played a role in dietary
deficiencies in our study. First, sodium intake per 1000 kcal
was not an independent predictor of event-free survival.
Second, sodium intake per 1000 kcal was greater in the high
micronutrient deficiency group than in the lower deficiency
group, indicating that the patients in the higher micronutrient
group were not consuming foods lower in sodium but rather
consuming smaller amounts of food.
The presence of depressive symptoms may be another
factor contributing to micronutrient deficiencies. Patients in
the high-deficiency group had significantly higher depressive
symptom scores than those in the lower deficiency group. The
variable of depressive symptoms was the only other one that
independently predicted event-free survival in the first model
and that remained a significant predictor in the second model.
This is consistent with an earlier study of a large sample of
patients in South Korea.42 Patients with depressive symptoms
in that study also had significantly more dietary micronutrient
deficiencies than patients with low depressive symptoms.
Furthermore, a synergistic negative effect of depressive
symptoms and nutrient deficiencies was demonstrated in
that study. Those with the shortest event-free survival were
patients with both depressive symptoms and a high number of
nutrient deficiencies, whereas those with the longest survival
had low depressive symptoms and few micronutrient
deficiencies.
It is important to highlight the relatively even distribution of
participants in the high-deficiency group across BMI cate-
gories. This finding is comparable to that of Shetty et al,53
who reported that the number of dietary micronutrient
deficiencies was similar in normal weight and overweight/
obese patients with heart failure. Many screening tools for
malnutrition (eg Geriatric Nutritional Risk Index, Mini Nutrition
Assessment, Nutritional Risk Index) include an anthropomet-
ric measure, most commonly BMI.54,55 Although such indexes
Figure. Kaplan–Meier plot of event-free survival by micronutrient deficiency status.
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predict outcomes in patients with heart failure, they may have
lower sensitivity for identifying malnutrition risk in patients
with high BMI. Our results suggest the need to assess dietary
quality of all patients with heart failure, especially over-
weight/obese patients who may otherwise be overlooked.
Some limitations are recognized. First, micronutrient defi-
ciencies were determined from 4-day food diaries collected at 1
time point. At a group level, we had diet data from food diaries
completed during all 12 months, but at an individual level,
diaries did not account for potential seasonal variability in
individual patients’ diets. Regardless, the consistency of our
findings with previous studies lends credence to our results;
however, the purpose of this study was to examine the effect of
overall diet quality rather than individualmicronutrients. Second,
our results demonstrate that a focus on single micronutrients
would be of limited value because deficiencies do not commonly
occur in isolation. The current focus on whole food-eating
patterns rather than targeted nutrients also limits interest in any
single nutrient.56 Third, our samplewas predominantlymalewith
few minorities and may not reflect other subpopulations of
patients with heart failure. Even though race was not a predictor
of time to event, the significantly higher number ofminority-race
patients in the high-deficiency group suggests that patients of
minority race/ethnicity may be more likely to have diets with
micronutrient deficiencies. Consequently, additional research is
needed that includes a more diverse sample to provide better
understanding of the relationships among patient characteris-
tics, nutritional intake, and outcomes in heart failure.
Several strengths of this study are noted. First, our sample of
patients with heart failure is the largest to date to provide
comprehensive dietary data. Second, our standardized protocol
for collection of food diary data was designed to ensure diaries
were as accurate and complete as possible. Recognizing that,
even under the best of circumstances, food diaries of some
patients will be inaccurate, we eliminated patients with diet
dairies thatwere not clinically plausible from the analysis. Finally,
we used the most rigorous method available to define dietary
micronutrient deficiencies,24 which increased confidence that
patients’ diets were habitually deficient in those micronutrients
rather than simply during the 4 days of the food diary.
Conclusion
The results of this study provide additional convincing
evidence that diet quality of patients with heart failure plays
an important independent role in heart failure outcomes. Our
results, combined with previous studies, suggest that patients
with comorbid depressive symptoms may be particularly
vulnerable to micronutrient deficiencies and shortened event-
free survival. However, the potential relationships among
depressive symptoms, diet, and event-free survival require
additional evidence before definitive conclusions can be
drawn. Calcium and magnesium intake appear to be nearly
universally deficient across multiple countries in Europe,
South America, Asia, and the United States. Although diet
monotony has been clinically observed and anecdotally noted
in our study, it has not been systematically documented in a
research study. Attention to contribution of diet monotony to
micronutrient deficiency in future research will help identify
potential interventions that achieve the goal determining ideal
eating patterns to promote optimal health among heart failure
patients of all ages.
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